On Thursday, TASER International, Inc. (NASDAQ:TASR)’s shares inclined 0.89% to $34.96.
TASER (TASR) declared multiple orders of its TASER® brand next generation Smart Weapons. These orders were received and shipped in the second quarter.
NoteworthyTASER Weapon orders:
- Arizona Department of Public Safety (AZ): 60 TASER® X2™ Smart Weapons, Officer Safety Plan.
- Atlanta Police Department (GA): 200 X2s with TASER®Cam™ HD recorders.
- Buncombe County Sheriff’s Office (NC): 50 X2s, TASER Assurance Plan (TAP).
- Camden County Prosecutors Office (NJ): 40 X2s with 34 TASER Cam HD recorders.
- Cleveland Metro Parks (OH): 85 TASER® X26P™ Smart Weapons.
- Cook County Sheriff’s Office (IL): 95 X2s and 100 X26Ps.
- Dallas Police Department (TX): 75.
- Denver Police Department (CO): 100 X26Ps.
- Eugene Police Department (OR): 60 X26Ps.
- Georgia Department of Corrections (GA): 140 X2s.
- International Order: 110 X26Ps.
- Mall of America Security Department (MN): 82 X26Ps.
- Metropolitan Nashville Police Department (TN): 100 X26Ps.
- Miami Police Department (FL): 180 X2s.
- Montgomery County Sheriff’s Department (TX): 44 X26Ps.
- Multnomah County Sheriff’s Office (OR): 100 X26Ps.
- New Orleans Police Department (LA): 350 X26Ps with TASER Cam HD recorders, upgrade.
- Oakland Police Department (CA): 60 X26Ps.
- Ohio Department of Public Safety Patrol Academy (OH): 70 X26Ps
- Ontario Provincial Police (ON): 279 X2s..
TASER International, Inc. develops, manufactures, and sells conducted electrical weapons (CEWs) worldwide. It operates through two segments, TASER Weapons and AXON. The company’s CEW products transmit electrical pulses along the wires and into the body affecting the sensory and motor functions of the peripheral nervous system. It offers three hand-held CEW product lines, counting TASER X26P and TASER X2, which integrates with EVIDENCE.com; and TASER X26.
Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA)’s shares gained 6.73% to $24.42.
Momenta Pharmaceuticals, Inc. (MNTA), declared that Sandoz has initiated its U.S. launch of once daily Glatopa(TM) (glatiramer acetate injection), a generic equivalent of daily COPAXONE(R) 20 mg, developed under a partnership agreement between Momenta and Sandoz. Glatopa is the first AP-rated substitutable generic indicated for the treatment of patients with relapsing-forms of multiple sclerosis (RRMS), a chronic disease of the central nervous system characterized by inflammation and neurodegeneration.
Under the terms of its partnership agreement with Sandoz, Momenta will receive a $10.0 million milestone payment upon first commercial sale. Momenta is also eligible to receive up to $120 million in remaining milestone payments upon the achievement of certain U.S. commercial and sales-based milestones for the Glatopa product.
Glatopa was determined by the FDA to be therapeutically equivalent to daily COPAXONE 20 mg, with the same active ingredients, route of administration, strength and dosage form. Glatopa’s high quality U.S.-based supply chain and manufacturing process meet rigid FDA standards, and Glatopa is fully substitutable at the pharmacy level.
Momenta Pharmaceuticals, Inc., a biotechnology company, focuses on developing generic versions of complex drugs, biosimilars, and novel therapeutics for oncology and autoimmune diseases. The company’s complex generics programs comprise Enoxaparin sodium injection, a generic version of Lovenox that is used for the prevention and treatment of deep vein thrombosis, and to support the treatment of acute coronary syndromes; and M356, a generic version of Copaxone, which is a complex drug comprising of a synthetic mixture of polypeptide chains for the treatment of patients with relapsing-remitting multiple sclerosis.
At the end of Thursday’s trade, Starwood Hotels & Resorts Worldwide Inc (NYSE:HOT)‘s shares surged 1.09% to $82.79.
Starwood Hotels & Resorts Worldwide, Inc. (HOT) declared the commencement of construction for its first-ever W and Element dual-branded hotel development, planned to open in the heart of downtown Philadelphia in early 2018. The 295-room W Philadelphia and 460-room Element Philadelphia will occupy a 51 story skyscraper located in the geographic center of the city’s business, arts and retail districts, and directly across from Philadelphia City Hall. Owned by Chestlen Development and developed by Vine Street Matthews Development, the highly-anticipated project will also boast panoramic city views and facilities comprise an outdoor pool bar and terrace, market-leading meeting and banquet facilities, exciting food and beverage outlets, and prime retail space along Chestnut Street.
Starwood Hotels & Resorts Worldwide, Inc., together with its auxiliaries, operates as a hotel and leisure company worldwide. The company owns, operates, and franchises luxury and upscale full-service hotels, resorts, residences, retreats, select-service hotels, and extended stay hotels under the St. Regis, The Luxury Collection, W, Westin, Le Méridien, Sheraton, Four Points, Aloft, and Element brand names.
Comerica Incorporated (NYSE:CMA), ended its Thursday’s trading session with -0.48% loss, and closed at $51.48.
Comerica Incorporated (CMA) will declare its second quarter 2015 earnings prior to the market opening on Friday, July 17, 2015.
Comerica will host a conference call to review second quarter 2015 financial results at 8 a.m. CT Friday, July 17, 2015. Interested parties may access the conference call by calling (877) 523-5249 or (210) 591-1147 (event ID No. 61399381). The call and a replay also will be accessible for one year via Comerica’s “Investor Relations” page at www.comerica.com.
Comerica Incorporated, through its auxiliaries, provides various financial products and services. It operates through three segments: Business Bank, Retail Bank, and Wealth Administration. The Business Bank segment offers various products and services, such as commercial loans and lines of credit, deposits, cash administration, capital market products, international trade finance, letters of credit, foreign exchange administration services, and loan syndication services to middle market businesses, multinational corporations, and governmental entities.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
